Intelligence ยท Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors โ phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text โ searchable for business development and competitive intelligence.
-
Realgar-Indigo Naturalis Formulation Combined with Anlotinib
The First People's Hospital of Lianyungang
Platinum-resistant Ovarian Cancer (PROC)
1 trial -
Recaticimab
The First People's Hospital of Lianyungang
STEMI - ST Elevation Myocardial Infarction
1 trial -
Recaticimab and Statin
The First People's Hospital of Lianyungang
Intracranial Atherosclerosis
1 trial -
Recombinant Human Adenovirus Type 5 injection
The First People's Hospital of Lianyungang
Hepatocellular Carcinoma
1 trial -
Recombinant Staphylokinase
The First People's Hospital of Lianyungang
ST-segment Elevation Myocardial Infarction (STEMI)
1 trial -
Recombinant Staphylokinase
The First People's Hospital of Lianyungang
Acute Myocardial Infarction
1 trial -
Recombinant staphylokinase
The First People's Hospital of Lianyungang
ST Elevation Myocardial Infarction
1 trial -
Recombinant subunit B/bacterial cholera vaccine (enteric-coated capsules)
United Therapeutics Europe Ltd
Diarrhea
1 trial -
Remimazolam Besylate for Injection
The First People's Hospital of Lianyungang
Thoracic Surgery
1 trial -
Repatha 140 mg solution for injection in pre-filled pen
Pari Pharma GmbH
acute myocardial infarction
1 trial -
Resveratrol
The First People's Hospital of Lianyungang
Pancreatitis, Acute
1 trial -
Revealยฎ XT Insertable Cardiac Monitor
Rhythm Pharmaceuticals Netherlands B.V.
Cryptogenic Symptomatic Transient Ischemic Attack
1 trial -
Rifaximin
The First People's Hospital of Lianyungang
IBS - Irritable Bowel Syndrome
1 trial -
Rifaximin
United Therapeutics Europe Ltd
Clostridium Difficile Infection
1 trial -
Rifaximin
COLLEGIUM PHARMACEUTICAL, INC
ACS - Acute Coronary Syndrome
1 trial -
Rifaximin Oral Tablet
Hospital Authority, Hong Kong
Irritable Bowel Syndrome With Diarrhea
1 trial -
Rituximab
The First People's Hospital of Lianyungang
Hemophagocytic Lymphohistiocytosis
1 trial -
Rivaroxaban 2.5 MG Oral Tablet [Xarelto]
The University of Hong Kong
Atherosclerosis, Coronary
1 trial -
Rocuronium
ELITE PHARMACEUTICALS INC /NV/
Muscle Relaxation
1 trial -
Rocuronium Bromide
ELITE PHARMACEUTICALS INC /NV/
Muscle Relaxation
1 trial -
Ropivacaine
The First People's Hospital of Lianyungang
Radius Fractures
1 trial -
Ropivacaine
The First People's Hospital of Lianyungang
End Stage Renal Disease (ESRD)
1 trial -
Rosuvastatin
The First People's Hospital of Lianyungang
Hyperlipidemia
1 trial -
Rosuvastatin (5mg๏ผ10mg๏ผ20mg)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Carotid Atherosclerosis
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1โ3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync โ verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources